CD8A and rectal cancer: In rectal cancer, not only is the high intra-tumoral CD8+ cell density associated with improved overall survival, but also the high density of PD-1+ and CD8+ immune cells before treatment is significantly correlated with favorable response to neoadjuvant chemoradiotherapy (CRT) and improved recurrence-free survival (10).